스마트 처방전 준수성 도구

집

AI 프롬프트 목록

의료 건강

처방전 심사 보조 도구

${:__('collect %s',처방전 심사 보조 도구)}$

의료 건강

약사가 잠재적인 약물 상호작용 및 용량 이상을 빠르게 식별하도록 지원하여 처방전 검토 효율성과 환자 약물 안전성을 향상시킵니다.

프롬프트 내용

복사

Act as a senior clinical pharmacist to review the following prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal impairment (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on evaluating the renal risks of NSAIDs in this patient population, check for drug-disease contraindications or dosage adjustment needs, and provide specific medication recommendations and risk warnings, ensuring the output is concise and professional.

복사

시니어 임상 약사로서 다음 처방전의 적합성을 검토하십시오. 환자는 65세 남성으로 2기 고혈압 및 경도 신기능 장애(eGFR 45ml/min) 진단을 받았습니다. 현재 투여 약물은 아몰로디핀 5mg 1일 1회, 아스피린 100mg 1일 1회, 이부프로펜 400mg 1일 3회입니다. 이 환자 집단에서 NSAIDs의 신장 위험을 중점적으로 평가하고, 약물-질병 금기 사항이나 용량 조정 필요성을 확인하며, 구체적인 약물 권장 사항과 위험 경고를 제공하십시오. 출력은 간결하고 전문적이어야 합니다.

복사

공유 링크를 복사하려면 클릭

의견 (0)

0/300

제출하다

추천

처방전 심사 보조

Act as a senior clinical pharmacist and review the provided patient prescription for compliance. Focus on analyzing potential drug-drug interactions, checking for incompatibilities, verifying if dosages align with the patient's age and renal/hepatic function, and ensuring no contraindications are violated. List all identified risks and provide optimization suggestions or alternatives based on the latest clinical guidelines to ensure medication safety and regulatory compliance.

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage appropriateness, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.

처방전 감사 어시스턴트

Acting as a senior clinical pharmacist in a hospital pharmacy, please conduct a compliance review of the following electronic prescription. The input includes patient demographics, medical history, current medication list, and details of the proposed drug. First, analyze potential drug-drug interactions, particularly focusing on metabolic impacts for patients with hepatic or renal impairment. Next, verify if the dosage aligns with the latest clinical guidelines and patient weight calculations. Finally, identify any contraindications or allergy conflicts, and output the audit conclusion in structured yet natural language, clearly stating whether risks exist, their severity, and suggested adjustments to ensure patient safety.

처방 감사 어시스턴트

Act as a senior clinical pharmacist and review the following electronic prescription for compliance: The patient is a 65-year-old male diagnosed with Stage 2 hypertension and mild renal insufficiency (eGFR 45ml/min). Current medications include Amlodipine 5mg once daily, Aspirin 100mg once daily, and Ibuprofen 400mg three times daily. Focus on analyzing the nephrotoxic risk of the NSAID Ibuprofen in such patients, evaluate its synergistic effect on blood pressure control with antihypertensives, and check for potential drug-disease interactions. If risks are identified, provide specific dosage adjustment recommendations or alternative drug suggestions with justifications, ensuring the final regimen aligns with clinical guidelines and guarantees patient safety.

처방전 심사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. Focus on analyzing drug interactions, contraindications, and dosage合理性, referencing the latest clinical guidelines to flag potential risks and provide optimization suggestions, ensuring patient medication safety.

처방전 감사 어시스턴트

Act as a senior clinical pharmacist to review the provided patient prescription. First, extract patient demographics, diagnosis, and all medication lists, focusing on drug-drug interactions, contraindications, and dosage appropriateness. Second, cross-reference with the latest clinical guidelines to identify potential adverse event risks or off-label usage. Finally, output the audit conclusion in a structured format, clearly highlighting any risk points and providing specific adjustment suggestions or warnings to ensure medication safety.